Class Actions News - Deborah Renner on Dart Cherokee Basin v. Owens
Polsinelli Podcasts - Class Action Lawsuits: What to do When the Claim Arrives
Blecker: GM Recalls Show Need for Harsher Penalties for "Red Collar" Criminals
Polsinelli Podcast - FDA Proposed Changes to Food Labels and What it May Mean for Manufacturers
Manufacturers, Importers and Retailers Must Take Action Following DTSC Reveal of Priority Products
Doing Business in California, Proposition 65, the California Green Chemical Initiative and the Rigid Plastic Packaging Regulations
Polsinelli Podcast - Food Safety Modernization Act
Bill on Bankruptcy: Delaware Garners Almost All Big Chapter 11s
Bill on Bankruptcy: Listening in the Dark at the NCBJ
Dean: Law Schools Use Merit Scholarships To Boost Rankings
Dean: Law Firms 'Support' NYLS's 2 Year Degree Program
Bill on Bankruptcy: LightSquared, the Battle among Hedge Funds
Bill on Bankruptcy: Appeals Court Changes the Law on Fraud
Bill on Bankruptcy: Make-Whole Premiums, Lehman, ResCap
Rice: Banking Lobby Won't Let New Glass-Steagall Bill Pass
Bar President: 3Ls Should Get Paid for Internships
Bill on Bankruptcy: Lawyers Must Disclose What Clients Pay
NALP: 18-Year Low for Law Grad Employment
Is Edward Snowden a Whistleblower?
Unique Privacy Concerns for Mobile Apps
On Tuesday, the U.S. Food and Drug Administration (FDA) announced that it has reopened the comment period for its proposed rule on generic drug labeling. It has also scheduled a day-long public meeting to hear comments and...more
It is a very common practice. Drug sales reps visit a client, usually a hospital, a clinic or a doctor, with the sole purpose of selling a drug or medical device. That is the primary way a doctor learns about a drug or...more
We use the same methodology, that Ecofin-Oecd apply for projecting expenditure in the medium-long term, to reconstruct expenditure in the medium-long past.
It is possible to compare the effective expenditure with the...more
NFLPA Investigates Buccaneers on MRSA Issue
by Anthony Caruso on September 11, 2013
The Tampa Bay Buccaneers may be in hot water over whether the team communicated the outbreak of MRSA - a dangerous bacteria resistant...more
In United States v. Caronia, No. 09-5006-cr, slip op. (2d Cir. Dec. 3, 2012), the U.S. Court of Appeals for the Second Circuit held that "the government cannot prosecute pharmaceutical manufacturers and their representatives...more
Lo sviluppo delle copie economiche dei farmaci off-patent e il bottleneck della distribuzione al dettaglio. Brevi riflessioni sull'Italia...more
Nel dibattito che accompagna i tentativi di riforma degli esercizi farmaceutici e della distribuzione del farmaco si continua, in maniera pretestuosa, a far riferimento a un presunto contrasto tra da un lato le indicazioni...more
Il copay che può far bene alal sanità e al Federalismo (di Nicola C. Salerno)
data = 20 Dicembre 2010...more
All’indomani dell’audizione del Presidente dell’Agcm Antonio Catricalà in Commissione Igiene e Sanità del Senato, questo Wp fa il punto sullo stato della distribuzione al dettaglio del farmaco...more
Nel dibattito che accompagna i tentativi di riforma degli esercizi farmaceutici e della distribuzione del farmaco, si è aggiunto, negli ultimi tempi, un argomento nuovo.
Un presunto contrasto tra da un lato le...more
Recent developments in pre-emption law have outlined the requirements for bringing an action against a manufacturer of an FDA approved medical device. Specifically, devices that undergo the 510(k) approval process remain a...more
Court Upholds New Hampshire Prescription Privacy Law.
Today, the First Circuit Court of Appeals upheld a New Hampshire law that bans the sale of prescriber-identifiable prescription drug data for marketing purposes. In...more
Maine Prescription Privacy Law Struck Down.
In IMS v. Rowe, the Maine federal district court held that the state prescription privacy law violated the First Amendment. The court held that the Act improperly restricted the...more
EPIC Urges Court to Consider Privacy Interest in De-Identified Patient Data.
EPIC and 16 experts in privacy and technology today filed a "friend of the court" brief in a case concerning a New Hampshire state law banning...more
New Hampshire Files Brief in First Circuit Appeal of Ayotte.
New Hampshire has filed its brief in the First Circuit Court of Appeals seeking reversal of the federal district court's decision striking down the state...more
New Hampshire Prescription Privacy Law Struck Down.
In IMS v. Ayotte, the New Hampshire federal district court held that the state Prescription Confidentiality Act violated the First Amendment. The court held that the Act...more
Find a Consumer Protection Author »
Back to Top